Showing results (201-210 of 322) with videos related to
Sort By:
Pageof 33
Bioorganic & Medicinal Chemistry|February 9, 2008
A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidinesJacobus P D van Veldhoven, Lisa C W Chang, Jacobien K von Frijtag Drabbe Künzel, et al.Biochemical Pharmacology|November 6, 2017
Kinetics of human cannabinoid 1 (CB1) receptor antagonists: Structure-kinetics relationships (SKR) and implications for insurmountable antagonismLizi Xia, Henk de Vries, Xue Yang, et al.Journal of Medicinal Chemistry|November 20, 2019
Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5Natalia V Ortiz Zacarías, Jacobus P D van Veldhoven, Lisa S den Hollander, et al.Journal of Medicinal Chemistry|August 15, 2017
Structure-Affinity Relationships and Structure-Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A3 Receptor AntagonistsLizi Xia, Wessel A C Burger, Jacobus P D van Veldhoven, et al.The Journal of Pharmacology and Experimental Therapeutics|January 26, 2008
G protein coupling and ligand selectivity of the D2L and D3 dopamine receptorsJ Robert Lane, Ben Powney, Alan Wise, et al.International Journal of Molecular Sciences|April 30, 2021
Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10Herman D Lim, J Robert Lane, Meritxell Canals, et al.Molecular Pharmacology|February 9, 2007
Protean agonism at the dopamine D2 receptor: (S)-3-(3-hydroxyphenyl)-N-propylpiperidine is an agonist for activation of Go1 but an antagonist/inverse agonist for Gi1,Gi2, and Gi3J Robert Lane, Ben Powney, Alan Wise, et al.Molecules (Basel, Switzerland)|July 2, 2021
Enantioenriched Positive Allosteric Modulators Display Distinct Pharmacology at the Dopamine D1 ReceptorTim J Fyfe, Peter J Scammells, J Robert Lane, et al.Journal of Medicinal Chemistry|June 18, 2016
Controlling the Dissociation of Ligands from the Adenosine A2A Receptor through Modulation of Salt Bridge StrengthElena Segala, Dong Guo, Robert K Y Cheng, et al.RSC Medicinal Chemistry|August 4, 2022
Development of subtype-selective covalent ligands for the adenosine A2B receptor by tuning the reactive groupBert L H Beerkens, Xuesong Wang, Maria Avgeropoulou, et al.Pageof 33